Cleared Traditional

K111861 - SYNGO.MR ONCO, SYNGO.MR 3D LESION SEGMENTATION, SYNGO.MR ONCO ENGINE

K111861 is an FDA 510(k) clearance for SYNGO.MR ONCO, manufactured by Siemens Medical Systems USA. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 190-day FDA review.

K111861 · Siemens Medical Systems USA · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2012
Decision
190d
Days
Class 2
Risk

K111861 is an FDA 510(k) clearance for the SYNGO.MR ONCO, SYNGO.MR 3D LESION SEGMENTATION, SYNGO.MR ONCO ENGINE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Siemens Medical Systems USA (Malvern, US). The FDA issued a Cleared decision on January 6, 2012 after a review of 190 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K111861

510(k) Number K111861 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 2011
Decision Date January 06, 2012
Days to Decision 190 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
PCCP Authorized No
Regulatory Context
Review time vs. panel average
83d slower than avg
Panel avg: 107d · This submission: 190d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2285
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K111861.
MCKESSON HORIZON CARDIOLOGY
K112720 · Mckesson Israel , Ltd. · Jan 2012
CAAS A-VALVE
K113076 · Pie Medical Imaging BV · Jan 2012
SWISSMEDA DENTAL PLANNING SYSTEM
K112251 · Swissmeda AG · Jan 2012
TOUCHPACS SUITE
K112008 · Touch Medical Solutions, Inc. · Jan 2012
DELTAVIEW MODEL 2.1
K111776 · Riverain Medical Group,Llc · Dec 2011
PROCEDURE REHEARSAL STUDIO(TM)
K112387 · Simbionix , Ltd. · Dec 2011
K111861 · SYNGO.MR ONCO, SYNGO.MR 3D LESION SEGMENTATION, SYNGO.MR ONCO ENGINE
Download PDF FDA Summary Siemens Medical Syste…